Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antisense Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 RNA Antisense Therapy
1.2.3 DNA Antisense Therapy
1.3 Market by Application
1.3.1 Global Antisense Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Cardiovascular
1.3.4 HBV
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antisense Therapy Market Perspective (2017-2028)
2.2 Antisense Therapy Growth Trends by Region
2.2.1 Antisense Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Antisense Therapy Historic Market Size by Region (2017-2022)
2.2.3 Antisense Therapy Forecasted Market Size by Region (2023-2028)
2.3 Antisense Therapy Market Dynamics
2.3.1 Antisense Therapy Industry Trends
2.3.2 Antisense Therapy Market Drivers
2.3.3 Antisense Therapy Market Challenges
2.3.4 Antisense Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense Therapy Players by Revenue
3.1.1 Global Top Antisense Therapy Players by Revenue (2017-2022)
3.1.2 Global Antisense Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Antisense Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antisense Therapy Revenue
3.4 Global Antisense Therapy Market Concentration Ratio
3.4.1 Global Antisense Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense Therapy Revenue in 2021
3.5 Antisense Therapy Key Players Head office and Area Served
3.6 Key Players Antisense Therapy Product Solution and Service
3.7 Date of Enter into Antisense Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense Therapy Breakdown Data by Type
4.1 Global Antisense Therapy Historic Market Size by Type (2017-2022)
4.2 Global Antisense Therapy Forecasted Market Size by Type (2023-2028)
5 Antisense Therapy Breakdown Data by Application
5.1 Global Antisense Therapy Historic Market Size by Application (2017-2022)
5.2 Global Antisense Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Antisense Therapy Market Size (2017-2028)
6.2 North America Antisense Therapy Market Size by Type
6.2.1 North America Antisense Therapy Market Size by Type (2017-2022)
6.2.2 North America Antisense Therapy Market Size by Type (2023-2028)
6.2.3 North America Antisense Therapy Market Share by Type (2017-2028)
6.3 North America Antisense Therapy Market Size by Application
6.3.1 North America Antisense Therapy Market Size by Application (2017-2022)
6.3.2 North America Antisense Therapy Market Size by Application (2023-2028)
6.3.3 North America Antisense Therapy Market Share by Application (2017-2028)
6.4 North America Antisense Therapy Market Size by Country
6.4.1 North America Antisense Therapy Market Size by Country (2017-2022)
6.4.2 North America Antisense Therapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Antisense Therapy Market Size (2017-2028)
7.2 Europe Antisense Therapy Market Size by Type
7.2.1 Europe Antisense Therapy Market Size by Type (2017-2022)
7.2.2 Europe Antisense Therapy Market Size by Type (2023-2028)
7.2.3 Europe Antisense Therapy Market Share by Type (2017-2028)
7.3 Europe Antisense Therapy Market Size by Application
7.3.1 Europe Antisense Therapy Market Size by Application (2017-2022)
7.3.2 Europe Antisense Therapy Market Size by Application (2023-2028)
7.3.3 Europe Antisense Therapy Market Share by Application (2017-2028)
7.4 Europe Antisense Therapy Market Size by Country
7.4.1 Europe Antisense Therapy Market Size by Country (2017-2022)
7.4.2 Europe Antisense Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antisense Therapy Market Size (2017-2028)
8.2 Asia-Pacific Antisense Therapy Market Size by Type
8.2.1 Asia-Pacific Antisense Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Antisense Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Antisense Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Antisense Therapy Market Size by Application
8.3.1 Asia-Pacific Antisense Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Antisense Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Antisense Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Antisense Therapy Market Size by Region
8.4.1 Asia-Pacific Antisense Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Antisense Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antisense Therapy Market Size (2017-2028)
9.2 Latin America Antisense Therapy Market Size by Type
9.2.1 Latin America Antisense Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Antisense Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Antisense Therapy Market Share by Type (2017-2028)
9.3 Latin America Antisense Therapy Market Size by Application
9.3.1 Latin America Antisense Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Antisense Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Antisense Therapy Market Share by Application (2017-2028)
9.4 Latin America Antisense Therapy Market Size by Country
9.4.1 Latin America Antisense Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Antisense Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense Therapy Market Size (2017-2028)
10.2 Middle East & Africa Antisense Therapy Market Size by Type
10.2.1 Middle East & Africa Antisense Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Antisense Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Antisense Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Antisense Therapy Market Size by Application
10.3.1 Middle East & Africa Antisense Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Antisense Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Antisense Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Antisense Therapy Market Size by Country
10.4.1 Middle East & Africa Antisense Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Antisense Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Details
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals Antisense Therapy Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022)
11.1.5 Alnylam Pharmaceuticals Recent Developments
11.2 Ionis Pharmaceuticals, Inc.
11.2.1 Ionis Pharmaceuticals, Inc. Company Details
11.2.2 Ionis Pharmaceuticals, Inc. Business Overview
11.2.3 Ionis Pharmaceuticals, Inc. Antisense Therapy Introduction
11.2.4 Ionis Pharmaceuticals, Inc. Revenue in Antisense Therapy Business (2017-2022)
11.2.5 Ionis Pharmaceuticals, Inc. Recent Developments
11.3 Arbutus Biopharma (Tekmira)
11.3.1 Arbutus Biopharma (Tekmira) Company Details
11.3.2 Arbutus Biopharma (Tekmira) Business Overview
11.3.3 Arbutus Biopharma (Tekmira) Antisense Therapy Introduction
11.3.4 Arbutus Biopharma (Tekmira) Revenue in Antisense Therapy Business (2017-2022)
11.3.5 Arbutus Biopharma (Tekmira) Recent Developments
11.4 Isarna Therapeutics
11.4.1 Isarna Therapeutics Company Details
11.4.2 Isarna Therapeutics Business Overview
11.4.3 Isarna Therapeutics Antisense Therapy Introduction
11.4.4 Isarna Therapeutics Revenue in Antisense Therapy Business (2017-2022)
11.4.5 Isarna Therapeutics Recent Developments
11.5 Arrowhead
11.5.1 Arrowhead Company Details
11.5.2 Arrowhead Business Overview
11.5.3 Arrowhead Antisense Therapy Introduction
11.5.4 Arrowhead Revenue in Antisense Therapy Business (2017-2022)
11.5.5 Arrowhead Recent Developments
11.6 Dicerna Pharmaceuticals
11.6.1 Dicerna Pharmaceuticals Company Details
11.6.2 Dicerna Pharmaceuticals Business Overview
11.6.3 Dicerna Pharmaceuticals Antisense Therapy Introduction
11.6.4 Dicerna Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022)
11.6.5 Dicerna Pharmaceuticals Recent Developments
11.7 Quark Pharmaceuticals
11.7.1 Quark Pharmaceuticals Company Details
11.7.2 Quark Pharmaceuticals Business Overview
11.7.3 Quark Pharmaceuticals Antisense Therapy Introduction
11.7.4 Quark Pharmaceuticals Revenue in Antisense Therapy Business (2017-2022)
11.7.5 Quark Pharmaceuticals Recent Developments
11.8 Benitec Biopharma
11.8.1 Benitec Biopharma Company Details
11.8.2 Benitec Biopharma Business Overview
11.8.3 Benitec Biopharma Antisense Therapy Introduction
11.8.4 Benitec Biopharma Revenue in Antisense Therapy Business (2017-2022)
11.8.5 Benitec Biopharma Recent Developments
11.9 Sylentis
11.9.1 Sylentis Company Details
11.9.2 Sylentis Business Overview
11.9.3 Sylentis Antisense Therapy Introduction
11.9.4 Sylentis Revenue in Antisense Therapy Business (2017-2022)
11.9.5 Sylentis Recent Developments
11.10 Gradalis
11.10.1 Gradalis Company Details
11.10.2 Gradalis Business Overview
11.10.3 Gradalis Antisense Therapy Introduction
11.10.4 Gradalis Revenue in Antisense Therapy Business (2017-2022)
11.10.5 Gradalis Recent Developments
11.11 Sarepta Therapeutics
11.11.1 Sarepta Therapeutics Company Details
11.11.2 Sarepta Therapeutics Business Overview
11.11.3 Sarepta Therapeutics Antisense Therapy Introduction
11.11.4 Sarepta Therapeutics Revenue in Antisense Therapy Business (2017-2022)
11.11.5 Sarepta Therapeutics Recent Developments
11.12 Biogen
11.12.1 Biogen Company Details
11.12.2 Biogen Business Overview
11.12.3 Biogen Antisense Therapy Introduction
11.12.4 Biogen Revenue in Antisense Therapy Business (2017-2022)
11.12.5 Biogen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer